Masaharu Mori
Corporate Officer/Principal chez Laboratoires OncoTherapy Science France SARL
Profil
Masaharu Mori is currently a Manager at Laboratoires OncoTherapy Science France SARL since 2014.
Prior to this, he was the President & Representative Director at OncoTherapy Science, Inc. from 2014 to 2017.
He also served as the President & Representative Director at Immunas Pharma, Inc. and as the President at Dojin Iyaku-Kako Co., Ltd.
Postes actifs de Masaharu Mori
| Sociétés | Poste | Début |
|---|---|---|
| Laboratoires OncoTherapy Science France SARL | Corporate Officer/Principal | 01/10/2014 |
Anciens postes connus de Masaharu Mori
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | President | 27/02/2017 |
Immunas Pharma, Inc.
 Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | President | - |
Dojin Iyaku-Kako Co., Ltd.
 Dojin Iyaku-Kako Co., Ltd. Pharmaceuticals: MajorHealth Technology Dojin Iyaku-Kaku Co., Ltd. is engaged in the development, production, and distribution of pharmaceutical products and pharmaceutical raw materials. The company was established in 1946 and is based in Tokyo, Japan. | President | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Dojin Iyaku-Kako Co., Ltd.
Dojin Iyaku-Kako Co., Ltd. Pharmaceuticals: MajorHealth Technology Dojin Iyaku-Kaku Co., Ltd. is engaged in the development, production, and distribution of pharmaceutical products and pharmaceutical raw materials. The company was established in 1946 and is based in Tokyo, Japan. | Health Technology |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
| Laboratoires OncoTherapy Science France SARL |
